MetaCap

Cryo-Cell International (CCEL) vs Mangoceuticals (MGRX)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Cryo-Cell International is the larger company by market cap ($33.5 million vs $2.7 million), about 12.2 times the size. Cryo-Cell International converts more of its revenue into profit, with a net margin of -7.7% versus -4526.8%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

CCEL+6.14%MGRX-72.14%
+44%-17%-78%
Oct 7, 20261 yearNov 20, 2026
CCEL-4.82%MGRX-70.71%
+24%-26%-75%
Oct 5, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

CCEL versus MGRX key metrics
MetricCCELMGRX
Share price$4.15$0.1236
Market cap$33.46M$2.75M
1-day change0.00%-7.55%
YTD return+20.64%—
1-year return+1.47%—
5-year return-66.34%—
Forward P/E207.50—
EPS (TTM)$-0.24$-0.52
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$31.57M$456.02K
Revenue growth (YoY)-1.31%-25.96%
Net income (latest FY)$-2.43M$-20.64M
Gross margin76.63%54.91%
Operating margin1.53%-3954.28%
Net margin-7.70%-4526.76%
52-week high$5.45$1.38
52-week low$2.72$0.121
Distance from 52-week high-23.85%-91.04%
Average volume13.02K638.90K
Shares outstanding8.06M22.22M
Employees723
SectorHealth CareHealth Care
IndustryMisc Health and Biotechnology ServicesMisc Health and Biotechnology Services

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • Cryo-Cell International is about 12.2 times larger than Mangoceuticals by market value ($33.46M vs $2.75M).
  • Cryo-Cell International is more profitable, keeping -7.7 cents of every revenue dollar as net income versus -4526.8 cents for Mangoceuticals.
  • Cryo-Cell International grew revenue faster in its latest fiscal year (-1.31% vs -25.96%).

About Cryo-Cell International

CCEL stock →

Cryo-Cell International, Inc. engages in cord blood and cord tissue cryopreservation services in the United States.

Health Care · Misc Health and Biotechnology Services · 72 employees

About Mangoceuticals

MGRX stock →

Mangoceuticals, Inc. engages in the development, marketing, and sale of various men's wellness products and services through a telemedicine platform in the United States.

Health Care · Misc Health and Biotechnology Services · 3 employees

CCEL vs MGRX FAQ

Which is bigger, Cryo-Cell International or Mangoceuticals?

Cryo-Cell International (CCEL) is larger, with a market capitalization of $33.46M compared with $2.75M for Mangoceuticals (MGRX).

Are Cryo-Cell International and Mangoceuticals in the same industry?

Yes. Both are classified in the Misc Health and Biotechnology Services industry within the Health Care sector.

More comparisons